Search

Your search keyword '"K V Raviteja"' showing total 4 results
Start Over Author "K V Raviteja" Search Limiters Full Text
4 results on '"K V Raviteja"'

1. Research on type 2 diabetes in India during 1982 to 2019: A comprehensive bibliometric assessment

Author

Devi Dayal, Brij M Gupta, K V Raviteja, Rimesh Pal, and Surinder M Dhawan

Subjects
bibliometrics, diabetes research, india, scientometrics, type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
Abstract

Background: India has an enormous burden of type 2 diabetes mellitus (T2DM), and this plays an important role in global T2DM research. However, the quantity and quality of Indian T2DM research remain largely unexplored. Objective: To provide a detailed analysis of Indian T2DM research output during 1982–2019 using select bibliometric indicators. Materials and Methods: Data on T2DM publications were retrieved from the Scopus database. The analysis focused on the quantitative output of Indian authors and organizations. The qualitative performance was assessed in terms of relative citation index, citations per paper, and highly cited papers. Results: Globally, 157 countries participated in T2DM research, producing 208902 publications during 1982–2019. India ranks in the ninth place in global output, with 7844 publications (3.75% share). Only 19.06% of papers had international collaboration, whereas 12% received funding. The leading productive organizations were the Madras Diabetes Research Foundation, Chennai, All India Institute of Medical Sciences (AIIMS), New Delhi, and Post Graduate Institute of Medical Education & Research, Chandigarh; whereas King Edward Memorial Hospital, Pune, AIIMS, New Delhi, and Fortis Healthcare, Gurgaon were the most impactful. The most productive authors were V. Mohan, S. Kalra, and A. Ramachandran. Journal of the Association of Physicians of India, Diabetes and Metabolic Syndrome Clinical Research and Reviews, and Journal of Clinical and Diagnostic Research were the leading productive journals. Only 2.23% of publications were highly cited. Conclusions: Considering the burden of T2DM, India’s research is lagging behind. Increasing national and international collaborations, active involvement of national and international funding agencies, and prioritizing research on youth with T2DM is the need of the hour.

Published
2021
Full Text
View/download PDF

2. Feasibility and acceptability of professional continuous glucose monitoring system in children with Type 1 diabetes mellitus: An observational study

Author

Rakesh Kumar, K V Raviteja, Naresh Sachdeva, and Devi Dayal

Subjects
Glucose sensors, professional continuous glucose monitoring, self-monitoring of blood glucose, type 1 diabetes mellitus, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
Abstract

Context: Professional continuous glucose monitoring (P-CGM) has been approved for use in adults and adolescents with type 1 diabetes mellitus (T1DM). There is dearth of data on its use and feasibility in children 70% was seen in 31 (73.8%) children. Common adverse events were local redness in 11 (26.2%), local irritation in 16 (38.1%) and parental anxiety in 12 (28.5%) children. Conclusions: There were no significant adverse effects noticed with Professional CGM (using iPro™2) and is feasible and acceptable to children (2–10 years) with T1DM as well as their caregivers.

Published
2019
Full Text
View/download PDF

3. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial

Author

K. V. Raviteja, Rakesh Kumar, Naresh Sachdeva, and Devi Dayal

Subjects
0301 basic medicine, Blood Glucose, Male, medicine.medical_specialty, endocrine system diseases, medicine.medical_treatment, lcsh:Medicine, Article, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Clinical efficacy, Longitudinal Studies, Adverse effect, Child, lcsh:Science, Glycemic, Glycated Hemoglobin, Type 1 diabetes, Multidisciplinary, Continuous glucose monitoring, business.industry, Blood Glucose Self-Monitoring, lcsh:R, nutritional and metabolic diseases, medicine.disease, Hypoglycemia, 030104 developmental biology, Diabetes Mellitus, Type 1, Treatment Outcome, Child, Preschool, Female, lcsh:Q, business, 030217 neurology & neurosurgery, Follow-Up Studies
Abstract

Frequent self-monitoring of blood glucose (SMBG) is the only accurate method available for insulin dose titration in patients with T1DM. Professional continuous glucose monitoring (p-CGM) is blinded recording of glucose trends over 5–7 days and helps physicians to guide insulin titration to patient. This study was planned to assess efficacy of insulin dose adjustments, based on p-CGM plus SMBG in improving glycemic control compared to SMBG alone. We did an open-label, parallel design, randomized control trial among children (2–10 years) having T1DM for at least 6 months. Subjects in the intervention group were placed on p-CGM (iPRO 2™ Professional CGM, Medtronic, USA) for 3–5 days along with regular SMBG. Data from p-CGM was analyzed by physician and used to guide insulin titration along with SMBG over following 3 months. Control group had only SMBG records for titrating insulin doses. Primary outcome was change in HbA1c 3 months after intervention. A total of 68 eligible children were randomized, 34 each to either arms. Thirty children in intervention group and 33 in control group completed the study and were analyzed. It was found that there was more decreased unit change in HbA1c, percentage of low sugar records and total insulin requirement per day, after 3 months follow-up, in intervention group. However, difference was not significant except for total insulin Units/kg/day (p = 0.014). In sub-group analysis of children with baseline HbA1c >7.5%, there was a significant mean fall of HbA1c by 1.27% (p = 0.045). There were no major adverse events associated with p-CGM. We conclude that addition of p-CGM along with SMBG may help in adjusting insulin dose more effectively especially in children with higher baseline HbA1c.

Published
2019

4. Feasibility and acceptability of professional continuous glucose monitoring system in children with Type 1 diabetes mellitus: An observational study

Author

K. V. Raviteja, Rakesh Kumar, Naresh Sachdeva, and Devi Dayal

Subjects
Pediatrics, medicine.medical_specialty, Type 1 diabetes, lcsh:RC648-665, endocrine system diseases, Continuous glucose monitoring, business.industry, nutritional and metabolic diseases, Context (language use), professional continuous glucose monitoring, self-monitoring of blood glucose, medicine.disease_cause, medicine.disease, lcsh:Diseases of the endocrine glands. Clinical endocrinology, Parental anxiety, medicine, General Earth and Planetary Sciences, Observational study, Glucose sensors, Irritation, Adverse effect, business, type 1 diabetes mellitus, General Environmental Science
Abstract

Context: Professional continuous glucose monitoring (P-CGM) has been approved for use in adults and adolescents with type 1 diabetes mellitus (T1DM). There is dearth of data on its use and feasibility in children 70% was seen in 31 (73.8%) children. Common adverse events were local redness in 11 (26.2%), local irritation in 16 (38.1%) and parental anxiety in 12 (28.5%) children. Conclusions: There were no significant adverse effects noticed with Professional CGM (using iPro™2) and is feasible and acceptable to children (2–10 years) with T1DM as well as their caregivers.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results